Evidence map›Paper›PMID 42422914›Full record

ArticleInternational forum of allergy & rhinology2026

The Utilization of the Completeness of Surgery Index in Revision Endoscopic Sinus Surgery Patients on Biologic Therapy for CRSwNP.

Isha Thapar, Margaret B Mitchell, Saawan D Patel, Vidit Talati, Jennifer E Douglas, Michael A Kohanski, Eric H Holbrook, Stacey T Gray, Benjamin S Bleier, Nithin D Adappa and 2 more

Abstract read
In one paragraph

Article in International forum of allergy & rhinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Isha ThaparDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Margaret B MitchellDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Saawan D PatelDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3185-7026
Vidit TalatiDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jennifer E DouglasDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-3634-2067
Michael A KohanskiDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-8399-364X
Eric H HolbrookDepartment of Otolaryngology, Massachusetts Eye and Ear/Harvard Medical School, Massachusetts, Boston, USA.ORCID https://orcid.org/0000-0002-7632-2204
Stacey T GrayDepartment of Otolaryngology, Massachusetts Eye and Ear/Harvard Medical School, Massachusetts, Boston, USA.
Benjamin S BleierDepartment of Otolaryngology, Massachusetts Eye and Ear/Harvard Medical School, Massachusetts, Boston, USA.
Nithin D AdappaDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
James N PalmerDepartment of Otorhinolaryngology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alan D WorkmanDepartment of Otolaryngology, Massachusetts Eye and Ear/Harvard Medical School, Massachusetts, Boston, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key pointsRevision surgery in patients on biologic therapy with lower preoperative CoSI scores (<70, reflecting previously incomplete surgery) resulted in significantly greater improvement in SNOT-22 after revision surgery compared to patients with previously adequate surgery. Incomplete prior surgery, as assessed by the CoSI, remains a likely correctable contributor to symptomatology even in patients receiving biologics.

Indexed as

Biological ProductsBiological TherapyEndoscopyParanasal SinusesRhinosinusitisHumansReoperationBiological Products

Identifiers

PMID42422914
PMCPMC13544445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.